Medicine & Life Sciences
pyrrolo(1,2-a)quinoxaline
100%
Inflammatory Bowel Diseases
89%
Lactones
61%
Epigenomics
49%
Drug Discovery
48%
Hydrazones
43%
SARS Virus
35%
Inflammation
34%
alkoxyl radical
32%
Pharmacology
31%
Oxygen
27%
Communicable Diseases
25%
Cations
23%
Nitrogen
23%
Therapeutics
23%
Chemokines
22%
Proteins
20%
Neoplasms
20%
Cytokines
18%
Crohn Disease
18%
Pyrroles
14%
G-Protein-Coupled Receptor Kinases
14%
Type 4 Cyclic Nucleotide Phosphodiesterase
13%
Pharmaceutical Preparations
13%
Tumor Necrosis Factor-alpha
13%
Receptor-Interacting Protein Serine-Threonine Kinases
13%
Epoxy Compounds
12%
Janus Kinases
12%
Inflammasomes
11%
Infections
11%
Morbidity
11%
Direction compound
11%
Structure-Activity Relationship
11%
Inflammatory Bowel Disease 4
10%
Opportunistic Infections
10%
Immunologic Factors
10%
Colitis
9%
Esters
9%
Neutralizing Antibodies
9%
Disease Management
9%
Ulcerative Colitis
9%
Drug Development
8%
Integrins
8%
Gastrointestinal Tract
8%
Adrenal Cortex Hormones
7%
Pathologic Constriction
7%
Colorectal Neoplasms
7%
Communication
7%
Chronic Disease
7%
Anti-Inflammatory Agents
6%
Chemical Compounds
Ring Expansion
54%
Drug Target
54%
Multicomponent Reaction
41%
Bromodomain-Containing Protein 4 Inhibitor
33%
Nitrogen
28%
Protein
19%
Hydrazone
17%
Molecule
16%
Disorder
13%
Eschenmoser-Tanabe Fragmentation
12%
Diastereoselectivity
11%
Dioxygen
11%
Lactone
11%
Protein Hydrolysis
8%
Refractory
8%
Bioavailability
7%
Modification
6%
Dipole
5%
Deprotonation
5%
Pyrrole
5%
Epoxide
5%
Ring Opening Reaction
5%